Literature DB >> 24661914

Isoflurane inhibits occludin expression via up-regulation of hypoxia-inducible factor 1α.

Jingyu Zhao1, Jianhua Hao2, Xiang Fei2, Xiaoyan Wang2, Yinan Hou2, Chengqi Deng2.   

Abstract

UNLABELLED: The blood-brain barrier (BBB) is a functional structure which regulates and restricts the transfer of circulating molecules and immune cells into the central nervous system. The barrier is formed by the presence of tight junctions (TJ) between the specialized brain endothelial cells. The volatile anesthetic isoflurane may affect the permeability of the BBB. Previous studies have proven that isoflurane alters hypoxia-inducible factor-1α (HIF-1α) expression, which may affect the TJ proteins; however, the mechanism of how TJ proteins are affected by isoflurane is still unclear. Primary human brain vascular endothelial cells (HBVEC) were exposed to isoflurane at various concentrations (0-2.5%) and different time periods (0-6 h). The cell viability, occludin expression, paracellular permeability, VEGF expression, TGF-β3 expression and occludin protein endocytosis were quantified. Isoflurane treatment induced a time- and concentration-dependent decrease in occludin mRNA and protein levels in HBVEC. This effect was partially abrogated by silencing the HIF-1α expression. Isoflurane could activate HIF-1α, and the overexpression HIF-1α up-regulated the level of VEGF and TGF-β3, VEGF decreased the expression of occludin and TGF-β3 accelerated the endocytosis of occludin. RNA interference targeting HIF-1α reduced both VEGF and TGF-β3 expression after isoflurane treatment.
CONCLUSION: This study provides direct evidence in vitro that exposing isoflurane to HBVECs can trigger HIF-1α activation, leading to lower protein levels of occludin, and increased permeability of the BBB.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Hypoxia inducible factor-1α; Isoflurane; Occludin; TGF-β3; VEGF

Mesh:

Substances:

Year:  2014        PMID: 24661914     DOI: 10.1016/j.brainres.2014.03.025

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

Review 1.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

2.  The Effects of Propofol on a Human in vitro Blood-Brain Barrier Model.

Authors:  Jason M Hughes; Olivia R Neese; Dylan D Bieber; Kirsten A Lewis; Layla M Ahmadi; Dustin W Parsons; Scott G Canfield
Journal:  Front Cell Neurosci       Date:  2022-05-11       Impact factor: 6.147

3.  Qihuang decoction promotes the recovery of intestinal immune barrier dysfunction after gastrectomy in rats.

Authors:  Hui Peng; Yi Shen; Qi Zhang; Juda Liu; Zhen Wang; Long Huang; Fuhai Zhou; Jian Yu; Mingyang Liu; Yiyang Yuan; Shushan Yu; Qingsheng Yu
Journal:  Am J Transl Res       Date:  2018-03-15       Impact factor: 4.060

4.  Therapeutic Target and Cell-signal Communication of Chlorpromazine and Promethazine in Attenuating Blood-Brain Barrier Disruption after Ischemic Stroke.

Authors:  Fengwu Li; Xiaokun Geng; James Yip; Yuchuan Ding
Journal:  Cell Transplant       Date:  2018-12-20       Impact factor: 4.064

5.  Effect of Intranasally Delivered rh-VEGF165 on Angiogenesis Following Cerebral Hypoxia-Ischemia in the Cerebral Cortex of Newborn Piglets.

Authors:  Amit Jain; Panagiotis Kratimenos; Ioannis Koutroulis; Amishi Jain; Amulya Buddhavarapu; Jahan Ara
Journal:  Int J Mol Sci       Date:  2017-11-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.